Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma

The implementation of immune checkpoint inhibitors (ICI) into the clinical management of different malignancies has largely changed our understanding of cancer treatment. After having proven efficacy in different tumor entities such as malignant melanoma and lung cancer, ICI were intensively tested...

詳細記述

保存先:
書誌詳細
出版年:Front Immunol
主要な著者: Mohr, Raphael, Jost-Brinkmann, Fabian, Özdirik, Burcin, Lambrecht, Joeri, Hammerich, Linda, Loosen, Sven H., Luedde, Tom, Demir, Münevver, Tacke, Frank, Roderburg, Christoph
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2021
主題:
Immunology
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8042255/
https://ncbi.nlm.nih.gov/pubmed/33859646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.652172
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料